Nov 25 2024
A study published in The Cureus Journal of Medical Science highlights the potential benefits of cannabinoid use for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Conducted by researchers from Concentra Urgent Care (Orlando), the University of Central Florida College of Medicine, the University of Alabama at Birmingham School of Medicine, and the University …
Nov 22 2024
With marijuana use surging among older adults, researchers are uncovering how it may influence age-related cognitive decline. A new study, published by the National Library of Medicine and as a preprint in bioRxiv, reveals that cannabis and Δ9-tetrahydrocannabinol (Δ9THC) may enhance working memory in aged individuals without worsening other cognitive impairments. The study concluded that …
Nov 21 2024
A recent study featured in the journal Pain Practice reveals that individuals living with chronic pain experience significant and sustained relief in pain severity and related symptoms through the use of medical marijuana. Drawing on data from the UK Medical Cannabis Registry, the research tracked patient-reported outcomes over a 12-month period, shedding light on the …
Nov 21 2024
According to a new study, marijuana-based medicines show promise in treating peripheral neuropathy, a chronic and debilitating condition often resistant to traditional nonsurgical treatments. The study, conducted by researchers from the University of Virginia, explored the potential of cannabis-based medications for managing pain and symptoms associated with peripheral neuropathy, including cases caused by nerve injury, …
Nov 20 2024
A study published in Clinical Parkinsonism & Related Disorders has found that the vast majority of those in France with Parkinson’s disease support medical marijuana and CBD use. In France, cannabis use is illegal outside the current restricted medical cannabis experimental framework which does not include Parkinson’s disease (PD) as an eligible condition. In contrast, …
Nov 19 2024
Lifetime cannabis use does not appear to negatively impact cognitive decline, and may actually protect against it, according to a longitudinal study published in Brain and Behavior. The research assessed the relationship between marijuana use and age-related cognitive changes in a cohort of 5,162 Danish men over a span of 44 years. Participants’ IQs were …
Nov 18 2024
According to a new study, hemp extract containing cannabidiol (CBD) and cannabidiolic acid (CBDA) may help mitigate the cognitive impairments and brain inflammation associated with chronic stress. Published in the Journal of Ethnopharmacology and conducted by researchers at Mae Fah Luang University, the study provides new insights into hemp’s potential neuroprotective properties. The researchers explored …
Nov 15 2024
A new systematic review from Utrecht University in the Netherlands explores the potential of minor cannabinoids in treating psychiatric disorders. Published in European Neuropsychopharmacology, the study offers fresh insight into how these lesser-known compounds might aid in addressing conditions such as anxiety, depression, and addiction. The research highlights the growing interest in cannabinoids for mental …
Nov 14 2024
Researchers at University Hospital of the Technical University of Munich have found that cannabidiol (CBD) may help protect lung endothelial cells from the harmful side effects of radiation, which they outline in a new study. Published in the journal Cancers, the study investigated CBD’s ability to shield the lung’s microvasculature from oxidative stress and inflammation …
Nov 13 2024
A new study conducted by researchers from Augusta University and The University of Texas Health Science Center at Houston has found that cannabidiol (CBD) may serve as a promising, cost-effective treatment for Alzheimer’s disease (AD). Published in the International Journal of Molecular Sciences, the study suggests that inhaled CBD could help improve cognitive function and …
